The Business Research Company’s global market reports are now updated with the latest market sizing information for the year 2023 and forecasted to 2032

The global anaphylaxis treatment market is expected to grow from $5.33 billion in 2022 to $5.73 billion in 2023 at a compound annual growth rate (CAGR) of 7.5%. The anaphylaxis treatment market is expected to reach $7.44 billion in 2027 at a CAGR of 6.8%.

North America held the largest anaphylaxis treatment market share, and  Asia-Pacific was the fastest-growing region in 2022.

Anaphylaxis Treatment Market Driver
The rise in the prevalence of food allergies is expected to propel the growth of the anaphylaxis treatment market going forward. Food allergy refers to an immune reaction to proteins in food. Anaphylaxis treatment helps to prevent the progression of life-threatening allergic symptoms involving the skin, mucosal surface, respiratory compromise, hypotension, and end-organ dysfunction. For instance, in January 2023, according to the Centers for Disease Control and Prevention, a US-based government agency, in 2021, 31.8% of adults aged 18 and older reported having eczema, a seasonal allergy, or a food allergy. One-fourth (25.7%) of adults had a seasonal allergy, 6.2% had a food allergy, and 7.3% of individuals had eczema. Therefore, the rise in the prevalence of food allergies is driving the growth of the anaphylaxis treatment market.

View More On The Anaphylaxis Treatment Market Report 2023 – https://www.thebusinessresearchcompany.com/report/anaphylaxis-treatment-global-market-report

Prominent Anaphylaxis Treatment Market Trend
Advancement in product development is a key trend gaining popularity in the anaphylaxis treatment market. Major companies operating in the anaphylaxis treatment market are advancing their products to sustain their position in the market. For instance, in April 2022, Aquestive Therapeutics Inc., a US-based pharmaceutical company, received Fast Track designation for AQST-109 for the treatment of severe allergic responses, including anaphylaxis, from the Food and Drug Administration. Aquestive is moving forward with the clinical testing of AQST-109, the first and only orally administered epinephrine product candidate that has demonstrated clinical outcomes equivalent to autoinjectors (such as EpiPen and Auvi-Q) for the treatment of allergic emergencies, including anaphylaxis.

Anaphylaxis Treatment Market Prominent Players
Major players in the anaphylaxis treatment market are Pfizer Inc., Merck & Co. Inc., Novartis International AG, Abbott Laboratories, GlaxoSmithKline plc, Viatris Inc., Teva Pharmaceutical Industries Ltd., Regeneron Pharmaceuticals Inc., Mylan N.V., Bausch Health Companies, Sun Pharmaceutical Industries Ltd., Perrigo Co, Dr. Reddy’s Laboratories Ltd., Hikma Pharmaceuticals plc, Amneal Pharmaceuticals Inc., ALK-Abelló A/S, Amphastar Pharmaceuticals Inc., Par Pharmaceutical Inc., Genentech Inc., MannKind Corporation, Meridian Medical Technologies LLC, Aquestive Therapeutics Inc., Sandoz Inc., Bioprojet SCR, Adamis Pharmaceutical Corporation, and Impax Laboratories LLC.

Request A Sample Of The Global Anaphylaxis Treatment Market Report 2023:
https://www.thebusinessresearchcompany.com/sample_request?id=12105&type=smp

Key Anaphylaxis Treatment Market Segments
The global anaphylaxis treatment market is segmented –
1) By Treatment: Epinephrine, Antihistamines, Steroids, Beta-antagonists, Other Treatments
2) By Product: Tablets, Capsules, Other Products
3) By Distribution Channel: Hospital Pharmacy, Retail Pharmacy, Online Pharmacy
4) By Application: Food Allergy, Pollen Allergy, Dust Mites Allergy, Other Applications

The Anaphylaxis Treatment Global Market Report 2023  provides a comprehensive overview on the anaphylaxis treatment market size, trends and drivers, opportunities, strategies, and companies analysis. The countries covered in the anaphylaxis treatment market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, the UK, and the USA, and the major seven regions are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, the Middle East, and Africa.

View More Related Reports –
Benign Prostatic Hyperplasia (BPH) Treatment Devices And Equipment Global Market Report 2023
Biosurfactants Global Market Report 2023
Hyperphosphatemia Treatment Global Market Report 2023

Contact us at:
The Business Research Company: https://www.thebusinessresearchcompany.com/
Americas +1 3156230293
Asia +44 2071930708
Europe +44 2071930708
Email us at [email protected]

Follow us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model